Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03184558
Title BGB324 in Combination With Pembrolizumab in Patients With TNBC
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors BerGenBio ASA
Age Groups: senior | adult
Covered Countries USA | GBR | ESP

Facility Status City State Zip Country Details
City of Hope Cancer Center Duarte California 91010-3012 United States Details
Sharp memorial Hospital, 7901 Frost Street, San Diego California 92123-2701 United States Details
Saint Luke's Cancer Institute Kansas City Missouri 64111 United States Details
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756 United States Details
Magee-Womens Hospital, UPMC Cancer Pavilion Pittsburgh Pennsylvania 15232-1309 United States Details
Haukeland University Hospital Bergen 5021 Norway Details
University General Hospital of Alicante Alicante 03010 Spain Details
Hospital Clinic i Provincial de Barcelona Barcelona 08036 Spain Details
Hospital Universitario Germans Trias i Pujol - Institut Catala d'Oncologia Barcelona 08916 Spain Details
Hospital Universitario Amau de Vilanova de Lieda, Servicio de Oncologia Lleida 25198 Spain Details
Hospital General Universitario Gregorio Maranon Madrid 28007 Spain Details
Hospital Universitario Ramon y Cajal Madrid 28034 Spain Details
Hospital Universitario Miguel Servet Zaragoza 50009 Spain Details
Beatson West of Scotland Cancer Centre Glasgow Scotland G12 0YN United Kingdom Details
Imperial College Healthcare NHS Trust, Charing Cross Hospital London W6 8RF United Kingdom Details
The Christie NHS Foundation Trust Manchester M20 4BX United Kingdom Details
Nottingham University Hospitals, City Campus, Hucknall Road Nottingham NG5 1 PB United Kingdom Details
*Shaded cells indicate that there was no data available from for the field